Auro Laboratories Ltd

Auro Laboratories Ltd Share Price Today: Live Updates & Key Insights

Get insights on Auro Laboratories Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Auro Laboratories Ltd Share Price Chart

null at 23 Dec 2025 03:21 PM null

N/A 0.00(0.00%)

Lowest Today 0.00

Highest Today 0.00

Today's Open 0.00

Prev. Close 0.00

52 Week High 0.00

52 Week Low 0.00

Auro Laboratories Ltd Fundamentals

Traded Volume: N/A

Market Cap(Cr): N/A

Avg Traded Price N/A

1 Year return %

Upper Circuit N/A

Lower Circuit N/A

P/E TTM 0.00

P/B Ratio 0.00

Traded Value(Cr) N/A

EPS TTM NaN

Book value/Share NaN

Dividend Yield 1Y 0.00%

Auro Laboratories Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Auro Laboratories Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Auro Laboratories Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W N/A%

1M N/A%

3M N/A%

1Y N/A%

YTD N/A%

Auro Laboratories Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Auro Laboratories Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday N/A

Day Before Yesterday N/A

1W Avg N/A

1M Avg N/A

3M Avg N/A

Auro Laboratories Ltd Technical Details

Auro Laboratories Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 N/A

Support 2 N/A

Support 3 N/A

Pivot Point : N/A

Resistance 1 N/A

Resistance 2 N/A

Resistance 3 N/A

Auro Laboratories Ltd Corporate Actions

Auro Laboratories Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Auro Laboratories Ltd’s capital allocation strategies.

All

Dividends

No Dividend has been declared by null

Bonus

No Bonus has been declared by null

Splits

No Split has been declared by null

Others

Rights No Rights has been declared by null

Auro Laboratories Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Auro Laboratories Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Auro Laboratories Ltd's relative performance and valuation against major competitors.

Stock Name Pharmaids Pharmaceuticals Ltd ₹48.50 (-3.00%) M. Cap (Cr) 1.71 1 Yr Return (%) -17.04% P/E (TTM) -12.86 PB Ratio 2.55

Stock Name Coral Laboratories Ltd ₹479.00 (+1.52%) M. Cap (Cr) 1.71 1 Yr Return (%) -35.36% P/E (TTM) 9.86 PB Ratio 0.84

Stock Name Astonea Labs Ltd ₹163.00 (+1.88%) M. Cap (Cr) 1.71 1 Yr Return (%) NaN% P/E (TTM) 32.02 PB Ratio 8.54

Stock Name Auro Laboratories Ltd ₹268.00 (+0.28%) M. Cap (Cr) 1.67 1 Yr Return (%) -1.02% P/E (TTM) 157.08 PB Ratio 3.86

Stock Name Balaxi Pharmaceuticals Ltd ₹28.94 (+3.32%) M. Cap (Cr) 1.60 1 Yr Return (%) -60.64% P/E (TTM) 10.92 PB Ratio 0.73

Stock Name Krebs Biochemicals & Industries Ltd ₹69.97 (-1.84%) M. Cap (Cr) 1.51 1 Yr Return (%) -30.93% P/E (TTM) -5.39 PB Ratio -1.01

Stock Name Parnax Lab Ltd ₹132.00 (+0.46%) M. Cap (Cr) 1.52 1 Yr Return (%) -19.85% P/E (TTM) 13.76 PB Ratio 1.92

Auro Laboratories Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Auro Laboratories Ltd, across its operating activities, investing activities, and financing activities.

Auro Laboratories Ltd Shareholding Pattern

This shows the ownership breakdown of Auro Laboratories Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter N/A%

Public N/A%

Other Institutions N/A%

FII N/A%

Mutual Funds N/A%

About Auro Laboratories Ltd

Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API). Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes. The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra. The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards. Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company`s primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments. Currently, it manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment. Additionally, it also undertake Toll/Custom Manufacturing for API`s and Intermediates on contract basis. The manufacturing facility operates are per cGMP norms and has an installed capacity in excess of 500 Tonnes per annum. Auro laboratories has made its presence felt in international markets with a bulk of it production being exported to South East Asia, Middle East and several European Countries. Some of the countries the company exports to are Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom. The Company received ISO 9001:2000 and WHO - cGMPs certification. It also received CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) in September 2006.

Chairman / Executive Director / M D / Promoter

Sharat Deorah

Registered office K-56 MIDC Indl Area, Tarapur Boisar, Thane, Maharashtra, 401506

FAX :91-22-66635456

Background

Incorporation Year 1989

Face Value ₹10.00

Market Lot 1

Auro Laboratories Ltd Latest News

VIEW MORE NEWS

FAQs on Auro Laboratories Ltd